Other drugs typically used to treat diabetes, such as metformin, zonisamide, and other GLP-1 RAs, are frequently administered “off-label” and at the doctor's discretion to treat obesity. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.